LIFEVANTAGE CORP Income (Loss) from Continuing Operations before Income Taxes, Domestic
LIFEVANTAGE CORP (LFVN) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $4.97 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-08-27
- LIFEVANTAGE CORP income (loss) from continuing operations before income taxes, domestic for fiscal 2026 was $4.97M, a 52.19% decline from fiscal 2025.
- LIFEVANTAGE CORP income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $10.40M, a 253.64% increase from fiscal 2024.
- LIFEVANTAGE CORP income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $2.94M, a 19.32% increase from fiscal 2023.
- LIFEVANTAGE CORP income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $2.46M, a 52.76% increase from fiscal 2022.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2026-06-30 | $4.97M 10-K · filed 2026-08-27 | |
| 2025-06-30 | $10.40M 10-K · filed 2026-08-27 | |
| 2024-06-30 | $2.94M 10-K · filed 2025-09-04 | |
| 2023-06-30 | $2.46M 10-K · filed 2024-08-28 | |
| 2022-06-30 | $1.61M 10-K · filed 2023-08-28 | |
| 2021-06-30 | $15.23M 10-K · filed 2022-08-23 | |
| 2020-06-30 | $12.82M 10-K · filed 2022-08-23 | |
| 2019-06-30 | $6.60M 10-K · filed 2021-08-19 | |
| 2018-06-30 | $8.23M 10-K · filed 2020-08-18 | |
| 2017-06-30 | $1.64M 10-K · filed 2019-08-14 | |
| 2016-06-30 | $7.52M 10-K · filed 2018-08-15 | |
| 2015-06-30 | $8.25M 10-K · filed 2017-09-07 | |
| 2014-06-30 | $13.89M 10-K · filed 2016-12-12 | |
| 2013-06-30 | $11.25M 10-K · filed 2015-09-01 | |
| 2012-06-30 | $14.56M 10-K · filed 2014-09-10 | $14.56M 10-K · filed 2012-09-10 |
| 2011-06-30 | -$50.53M 10-K · filed 2013-09-12 | -$50.53M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |